Caffeine vs. Guarana: Can AI Predict Which Stimulant Packs the Bigger Punch?
AI-driven analysis reveals guarana offers more sustained cognitive stimulation than caffeine, due to additional bioactive compounds and slower caffeine release…
LDL-C–Lowering Inclisiran May Carry Lower Risk of Diabetes Than Atorvastatin
Inclisiran was found to have a lower risk causing new-onset diabetes compared with other low-density lipoprotein cholesterol (LDL-C)-lowering therapies.
Study Finds Association Between Lung Cancers and Ultra-Processed Foods
Recent data link a higher consumption of ultra-processed food to increased lung cancer risk, highlighting the need for dietary changes…
Can Cilta-Cel Redefine Outcomes in Multiple Myeloma?
CARTITUDE-1 data show one-third of patients treated with cilta-cel remain progression-free at 5 years without maintenance.
Pharmacy Orgs Urge Court to Uphold Tennessee’s Right to Regulate PBMs
Without regulation, PBMs have engaged in abusive practices, say pharmacy groups.
Multiple Myeloma: A Modern Look at an Ancient Disease and 2025’s Therapeutic Breakthroughs
Discover the latest advancements in multiple myeloma treatment, including new therapies and FDA approvals that enhance patient outcomes and survival…
Examining the One Big Beautiful Bill Act on Prescription Drugs: Benefits and Criticisms
The bill promises lower drug costs and greater innovation, but critics still have concerns.
Will the “Big, Beautiful Bill” Accelerate the Direct Buy and Direct Pay Marketplace?
Another bill, another day for the erosion of pharmacy benefits as a means of affording a prescription.
